Concepedia

Race and Drug Formulation Influence on Mycophenolic Acid Pharmacokinetics in Stable Renal Transplant Recipients

Kathleen M. Tornatore, Patcharaporn Sudchada, Kristopher Attwood, Gregory E. Wilding, Aijaz C. Gundroo, Robin DiFrancesco, Vanessa Gray, Rocco C. Venuto

The Journal of Clinical Pharmacology · 2012 · 15 citations · 21 references

DOI

Abstract

Race influences MPA exposure between MMF and EC-MPS and may warrant therapeutic monitoring during formulation conversion.

References

21

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group · Transplantation · 1996 · 1.1K citations

, , +14

Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection

The Lancet · 1995 · 929 citations

, , +5

Clinical Pharmacy: Case Studies

Margaret M. McCarron, Ben J. Devine · Drug Intelligence & Clinical Pharmacy · 1974 · 340 citations

, , +3

Cyclosporine Interacts with Mycophenolic Acid by Inhibiting the Multidrug Resistance-Associated Protein 2

Dennis A. Hesselink, Reinier M. van Hest, Ron A. A. Mathôt et al. · American Journal of Transplantation · 2005 · 297 citations

, , +6

Enteric-Coated Mycophenolate Sodium can be Safely Administered in Maintenance Renal Transplant Patients: Results of a 1-Year Study

Klemens Budde, John J. Curtis, Greg Knoll et al. · American Journal of Transplantation · 2004 · 263 citations

, , +7